Novo Nordisk  

Monitoring Quality of Care

Protocol for quality development and monitoring of performance

Aggregate

the data gathered at Annual Review onto a computerized database

Choose

indicators ( see below ) to reflect outcome as well as process of care

Analyze

data in line with published recommendations

Compare

performance with pre-determined standards or other providers of diabetes care

Review

performance at regular meetings of your diabetes team

Discuss

the performance of education programmes
Indicators for quality development and monitoring
Measure Calculate
Intermediate outcomes
HbA1c Percent >7.5 %Hb
Albumin excretion Percent abnormal albumin excretion
Eye damage Percent with retinal damage
True outcomes
Amputation above ankle Incidence
Myocardial infarction Incidence
Stroke Incidence
Foot ulceration Incidence
Risk factor control
Hypertension Percent >= 135/85 mmHg
Smoking Percent people still smoking
Process of care
Eyes screened Percent people examined in year
Education performed Percent people seeing nurse educator in year
Feet examined Percent people examined in year
These are examples; many other indicators are possible

 

IDF Guidelines to Type 1 diabetes
Click here for 'Topic Finder'

Ensure effective delivery of care
Framework of Diabetes Care
The Diabetes Consultation
Organization of Clinical Monitoring
Monitoring Quality of Care
Click here for 'Promote effective self-care'
Click here for 'Control blood glucose, blood lipids, arterial factors'
Click here for 'Detect and manage diabetes complications'
Click here for 'Manage special problems'
Click here for 'Index'



Novo Nordisk Click here to return to the top of the page